Senior insider sale
Chief Scientific Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$194.5K
17.03K shares
What this filing means
HEIER JEFFREY S. plans to sell 17.03K shares of OCULAR THERAPEUTIX, INC valued at approximately $194.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/24/2025ACC: 0001950047-25-009281
Officer· Chief Scientific Officer
Since Feb 2026
17.03K
Shares to sell
$194.5K
Approx. market value
3.47K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
11/22/2025
3.47KTotal acquired3.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/22/2025 | Restricted stock vesting under a registered plan Not Applicable | 3.47K | — |
| Total | 3.47K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10.50K
Market value
$115.9K
10/2/2025
—Completed
Units to sell
3.06K
Market value
$36.9K
8/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.47K
Market value
$41.8K
11/24/2025
Total
Units
17.03K
Value
$194.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/2/2025 | 10.50K | $115.9K | — | Completed |
8/25/2025 | 3.06K | $36.9K | — | Completed |
| Planned — Approximate Date | ||||
11/24/2025 | 3.47K | $41.8K | NASDAQ | Planned |
| Total | 17.03K | $194.5K | ||